88 related articles for article (PubMed ID: 18814453)
1. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
Kaiser H; Parasuraman B; Boggs R; Miller CJ; Leidy NK; O'Dowd L
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
[TBL] [Abstract][Full Text] [Related]
2. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
Jonkers RE; Bantje TA; Aalbers R
Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916
[TBL] [Abstract][Full Text] [Related]
3. ADRB2 polymorphisms and budesonide/formoterol responses in COPD.
Bleecker ER; Meyers DA; Bailey WC; Sims AM; Bujac SR; Goldman M; Martin UJ
Chest; 2012 Aug; 142(2):320-328. PubMed ID: 22383665
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.
Price DB; Thomas V; Richard Dekhuijzen PN; Bosnic-Anticevich S; Roche N; Lavorini F; Raju P; Freeman D; Nicholls C; Small IR; Sims E; Safioti G; Canvin J; Chrystyn H
BMC Pulm Med; 2018 Jun; 18(1):107. PubMed ID: 29954359
[TBL] [Abstract][Full Text] [Related]
5. Budesonide/formoterol combination in COPD: a US perspective.
Sharafkhaneh A; Mattewal AS; Abraham VM; Dronavalli G; Hanania NA
Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():357-66. PubMed ID: 21037960
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vitro and in vivo flow rate dependency of budesonide/formoterol Easyhaler(®).
Malmberg LP; Everard ML; Haikarainen J; Lähelmä S
J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):329-40. PubMed ID: 24978441
[TBL] [Abstract][Full Text] [Related]
7. Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.
Karjalainen J; Vartiainen V; Tikkakoski A; Malmberg LP; Vuotari L; Lähelmä S; Sairanen U; Vahteristo M; Lehtimäki L
Respir Med; 2024; 230():107693. PubMed ID: 38851404
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Efficiency of Single-Inhaler Combination Therapy with Budesonide/Formoterol Fumarate in Patients with Bronchial Asthma in Daily Clinical Practice.
Pirożyński M; Hantulik P; Almgren-Rachtan A; Chudek J
Adv Ther; 2017 Dec; 34(12):2648-2660. PubMed ID: 29119403
[TBL] [Abstract][Full Text] [Related]
9. Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism.
Lavorini F; Geri P; Mariani L; Marmai C; Maluccio NM; Pistolesi M; Fontana GA
Br J Clin Pharmacol; 2006 Oct; 62(4):403-11. PubMed ID: 16995861
[TBL] [Abstract][Full Text] [Related]
10. Doxofylline as a steroid-sparing treatment in Mexican children with asthma.
González-Díaz SN; Ansotegui IJ; Macouzet-Sánchez C; Acuña-Ortega N; de la Cruz-de la Cruz C
J Asthma; 2024 Jun; 61(6):574-583. PubMed ID: 38153316
[TBL] [Abstract][Full Text] [Related]
11. Management of severe asthma in children.
Bush A; Saglani S
Lancet; 2010 Sep; 376(9743):814-25. PubMed ID: 20816548
[TBL] [Abstract][Full Text] [Related]
12. The carbon footprint of as-needed budesonide-formoterol in mild asthma: a post hoc analysis.
Hatter L; Holliday M; Eathorne A; Bruce P; Pavord ID; Reddel HK; Hancox RJ; Papi A; Weatherall M; Beasley R
Eur Respir J; 2024 Apr; ():. PubMed ID: 38609096
[TBL] [Abstract][Full Text] [Related]
13. Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance.
Darbà J; Ramírez G; Sicras A; García-Bujalance L; Torvinen S; Sánchez-de la Rosa R
Patient Prefer Adherence; 2016; 10():135-45. PubMed ID: 26929605
[TBL] [Abstract][Full Text] [Related]
14. Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents.
Strunk RC; Sternberg AL; Szefler SJ; Zeiger RS; Bender B; Tonascia J;
J Pediatr; 2009 May; 154(5):682-7. PubMed ID: 19167726
[TBL] [Abstract][Full Text] [Related]
15. As needed ICS/formoterol: not all of Europe is equal.
Bush A; Randerath W; Roche N
Eur Respir J; 2024 May; 63(5):. PubMed ID: 38806204
[No Abstract] [Full Text] [Related]
16. Identification of asthma phenotypes in a tertiary care medical center.
Kuhlen JL; Wahlquist AE; Nietert PJ; Bains SN
Am J Med Sci; 2014 Dec; 348(6):480-5. PubMed ID: 25319436
[TBL] [Abstract][Full Text] [Related]
17. Inhalation devices.
CMAJ; 2005 Sep; 173(6 Suppl):S39-45. PubMed ID: 16157736
[No Abstract] [Full Text] [Related]
18. Application of different counseling strategies for better adult asthma control.
Mohamed BME; Laz N; Saeed H; Alghamdi S; AbdElrahman M; Abdelrahim MEA; Rabea H
J Asthma; 2024 Jul; 61(7):677-684. PubMed ID: 38153520
[TBL] [Abstract][Full Text] [Related]
19. Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program.
Wysocki K; Park SY; Bleecker E; Busse W; Castro M; Chung KF; Gaston B; Erzurum S; Israel E; Teague WG; Moore CG; Wenzel S
J Allergy Clin Immunol; 2014 Mar; 133(3):915-8. PubMed ID: 24332222
[No Abstract] [Full Text] [Related]
20. Efficacy-based comparison between adults and children regarding using advanced counseling for asthma.
Mohamed BME; Laz N; Saeed H; Abdelrahim MEA; Rabea H
J Asthma; 2024 May; ():1-7. PubMed ID: 38742886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
